BACKGROUND: Sensitization to cockroach allergens is a major risk factor for asthma. The cockroach allergen Bla g 1 has multiple repeats of approximately 100 amino acids, but the fold of the protein and its biological function are unknown. OBJECTIVE: We sought to determine the structure of Bla g 1, investigate the implications for allergic disease, and standardize cockroach exposure assays. METHODS: nBla g 1 and recombinant constructs were compared by using ELISA with specific murine IgG and human IgE. The structure of Bla g 1 was determined by x-ray crystallography. Mass spectrometry and nuclear magnetic resonance spectroscopy were used to examine the ligand-binding properties of the allergen. RESULTS: The structure of an rBla g 1 construct with comparable IgE and IgG reactivity to the natural allergen was solved by x-ray crystallography. The Bla g 1 repeat forms a novel fold with 6 helices. Two repeats encapsulate a large and nearly spherical hydrophobic cavity, defining the basic structural unit. Lipids in the cavity varied depending on the allergen origin. Palmitic, oleic, and stearic acids were associated with nBla g 1 from cockroach frass. One unit of Bla g 1 was equivalent to 104 ng of allergen. CONCLUSIONS: Bla g 1 has a novel fold with a capacity to bind various lipids, which suggests a digestive function associated with nonspecific transport of lipid molecules in cockroaches. Defining the basic structural unit of Bla g 1 facilitates the standardization of assays in absolute units for the assessment of environmental allergen exposure. Published by Mosby, Inc.
BACKGROUND: Sensitization to cockroach allergens is a major risk factor for asthma. The cockroach allergen Bla g 1 has multiple repeats of approximately 100 amino acids, but the fold of the protein and its biological function are unknown. OBJECTIVE: We sought to determine the structure of Bla g 1, investigate the implications for allergic disease, and standardize cockroach exposure assays. METHODS: nBla g 1 and recombinant constructs were compared by using ELISA with specific murine IgG and humanIgE. The structure of Bla g 1 was determined by x-ray crystallography. Mass spectrometry and nuclear magnetic resonance spectroscopy were used to examine the ligand-binding properties of the allergen. RESULTS: The structure of an rBla g 1 construct with comparable IgE and IgG reactivity to the natural allergen was solved by x-ray crystallography. The Bla g 1 repeat forms a novel fold with 6 helices. Two repeats encapsulate a large and nearly spherical hydrophobic cavity, defining the basic structural unit. Lipids in the cavity varied depending on the allergen origin. Palmitic, oleic, and stearic acids were associated with nBla g 1 from cockroach frass. One unit of Bla g 1 was equivalent to 104 ng of allergen. CONCLUSIONS:Bla g 1 has a novel fold with a capacity to bind various lipids, which suggests a digestive function associated with nonspecific transport of lipid molecules in cockroaches. Defining the basic structural unit of Bla g 1 facilitates the standardization of assays in absolute units for the assessment of environmental allergen exposure. Published by Mosby, Inc.
Entities:
Keywords:
Allergen; Bla g 1; GFP; GST; Glutathione-S-transferase; Green fluorescent protein; MS; Mass spectrometry; NMR; NSP; Nitrile-specifier protein; Nuclear magnetic resonance spectroscopy; PC; PE; PG; PI; Phosphatidylcholine; Phosphatidylethanolamine; Phosphatidylglycerol; Phosphatidylinositol; Recombinant Bla g 1 expressed in Escherichia coli; Recombinant Bla g 1 expressed in Pichia pastoris; Recombinant Bla g 1 with an N-terminal GFP; TEV; TLR; Tobacco etch virus; Toll-like receptor; asthma; cockroach; exposure assessment; ligand-binding proteins; rBla g 1–EC; rBla g 1–GFP; rBla g 1–PP; structure
Authors: Samuel J Arbes; Michelle Sever; Jigna Mehta; J Chad Gore; Coby Schal; Ben Vaughn; Herman Mitchell; Darryl C Zeldin Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: Geoffrey A Mueller; Lori L Edwards; Jim J Aloor; Michael B Fessler; Jill Glesner; Anna Pomés; Martin D Chapman; Robert E London; Lars C Pedersen Journal: J Allergy Clin Immunol Date: 2010-03-11 Impact factor: 10.793
Authors: Ute Wittstock; Niels Agerbirk; Einar J Stauber; Carl Erik Olsen; Michael Hippler; Thomas Mitchell-Olds; Jonathan Gershenzon; Heiko Vogel Journal: Proc Natl Acad Sci U S A Date: 2004-03-29 Impact factor: 11.205
Authors: Stephanie C Eisenbarth; Damani A Piggott; James W Huleatt; Irene Visintin; Christina A Herrick; Kim Bottomly Journal: J Exp Med Date: 2002-12-16 Impact factor: 14.307
Authors: Anna Pomés; Janet M Davies; Gabriele Gadermaier; Christiane Hilger; Thomas Holzhauser; Jonas Lidholm; Andreas L Lopata; Geoffrey A Mueller; Andreas Nandy; Christian Radauer; Sanny K Chan; Uta Jappe; Jörg Kleine-Tebbe; Wayne R Thomas; Martin D Chapman; Marianne van Hage; Ronald van Ree; Stefan Vieths; Monika Raulf; Richard E Goodman Journal: Mol Immunol Date: 2018-04-04 Impact factor: 4.407
Authors: L Karla Arruda; Michelle C R Barbosa; Ana Beatriz R Santos; Adriana S Moreno; Martin D Chapman; Anna Pomés Journal: Curr Allergy Asthma Rep Date: 2014-04 Impact factor: 4.806
Authors: Anna Pomés; Geoffrey A Mueller; Thomas A Randall; Martin D Chapman; L Karla Arruda Journal: Curr Allergy Asthma Rep Date: 2017-04 Impact factor: 4.806
Authors: Anna Pomés; Jill Glesner; Agustin Calatroni; Cindy M Visness; Robert A Wood; George T O'Connor; Meyer Kattan; Leonard B Bacharier; Lisa M Wheatley; James E Gern; William W Busse Journal: J Allergy Clin Immunol Date: 2019-06-13 Impact factor: 10.793
Authors: Anna Pomés; Maksymilian Chruszcz; Alla Gustchina; Wladek Minor; Geoffrey A Mueller; Lars C Pedersen; Alexander Wlodawer; Martin D Chapman Journal: J Allergy Clin Immunol Date: 2015-07 Impact factor: 10.793